IRIS
PELUSO, ANNA LUCIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 461
EU - Europa 148
NA - Nord America 87
SA - Sud America 73
AF - Africa 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 773
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 152
IT - Italia 134
CN - Cina 108
US - Stati Uniti d'America 70
KR - Corea 64
IL - Israele 60
BR - Brasile 57
VN - Vietnam 42
HK - Hong Kong 18
MX - Messico 17
AR - Argentina 8
DE - Germania 6
BD - Bangladesh 5
ID - Indonesia 5
EC - Ecuador 3
RU - Federazione Russa 3
EG - Egitto 2
UA - Ucraina 2
AE - Emirati Arabi Uniti 1
CL - Cile 1
CO - Colombia 1
IN - India 1
IQ - Iraq 1
JP - Giappone 1
MA - Marocco 1
NL - Olanda 1
PE - Perù 1
PK - Pakistan 1
PL - Polonia 1
PS - Palestinian Territory 1
PY - Paraguay 1
SA - Arabia Saudita 1
SE - Svezia 1
VE - Venezuela 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 773
Salva come PNG Salva come JPEG
Città #
Singapore 74
Chicago 64
Pescara 64
Seoul 64
Rome 60
Tel Aviv 60
Beijing 18
Hong Kong 18
Mexico City 14
Ho Chi Minh City 13
Hanoi 7
Milan 4
Brasília 3
Hangzhou 3
Belo Horizonte 2
Bắc Ninh 2
Can Tho 2
Curitiba 2
Da Nang 2
Guayaquil 2
Haiphong 2
Nam Định 2
Naples 2
Osasco 2
Recife 2
Ribeirão Preto 2
Salvador 2
São Paulo 2
Thái Nguyên 2
Ajman 1
Al Mansurah 1
Allen 1
Americana 1
Barra do Piraí 1
Biên Hòa 1
Brumadinho 1
Campina Grande 1
Campinas 1
Cananéia 1
Canoas 1
Cape Girardeau 1
Carapicuíba 1
Casablanca 1
Castanhal 1
Ciudad Evita 1
Ciudad Guayana 1
Clorinda 1
Cuenca 1
Cusco 1
Dammam 1
Dhaka 1
Diamantino 1
Dokki 1
Dom Eliseu 1
Dębica 1
Formiga 1
Formosa 1
Guajeru 1
Hidrolândia 1
Hòa Bình 1
Ibiúna 1
Itajaí 1
Jaguaquara 1
Joinville 1
Karachi 1
La Banda 1
Lontras 1
Luis Eduardo Magalhães 1
Luque 1
Mitrovica 1
Mongaguá 1
Mosul 1
Mumbai 1
Nablus 1
Naucalpan 1
Nha Trang 1
Ninh Bình 1
Oliveira 1
Osório 1
Palmeira 1
Pekanbaru 1
Petrolina 1
Petrópolis 1
Phủ Lý 1
Piracicaba 1
Piracuruca 1
Porto Alegre 1
Quilmes 1
Quixadá 1
Quận Bình Thạnh 1
Riachão das Neves 1
Rimini 1
San Fernando 1
San Luis Potosí City 1
Santa Fe 1
Santiago 1
Santiago de Cali 1
Santo André 1
Sevastopol 1
Shanghai 1
Totale 567
Salva come PNG Salva come JPEG
Nome #
Risorse genetiche di organismi utili per il miglioramento di specie di interesse agrario e per un'agricoltura sostenibile 22
The A1059E mutation in Jak2 gene was detected in patients with Idiopathic Erithrocytosis secondary to Acute Lymphoblastic Leukemia 17
Attivazione di una immunità specifica per PRAME mediante l'utilizzo di una libreria peptidica in pazienti affetti da patologie ematologiche 16
Evaluation of proteolytic, lipolytic and decarboxylase activity of extremely halophilic bacteria occurring in ripening of salt anchovies 16
Acute and Chronic Ph+ leukemias: differential leukemogenesis pathways translate into different clinical needs 16
Increasing BCR-ABL expression levels and/or occurrence of ABL point mutations not always predict resistance to Imatinib Mesylate in BCR-ABL positive Acute Lymphoblastic Leukemia 15
Heat Shock Protein 90 (HSP90) regulates the expression of preferentially Expressed Antigen of Melanoma (PRAME) in cell lines derived from patients with Chronic Myeloid Leukemia 15
A particular mutational status in a Chronic Myeloid Leukemia patient treated with different tyrosine-Kinase inhibitors 15
Ligh chains expression of lymphoid infiltrate in fine-needle cytology of Hashimoto's Thyroiditis 15
Caratterizzazione dei ceppi di Rhizobium spp. Simbionti di leguminose selvatiche e coltivate del climax mediterraneo 15
Deletion and insertion events in tyrosine Kinase domain of BCR-ABL is a common phenomenon in Chronic Myeloid Leukemia 15
Mesenchymal stem cell (MSC) derived from bone marrow (BM) of patients with Chronic Myelogenous Leukemia protect Ph+ leukemic cells from TKI induced apoptosis 15
Unravelling the mechanism of resistance to Imatinib Mesylate in Chronic Myeloid Leukemia: a proteomic approach 15
Characterization of Rhizobium spp.strains symbionts of wild and cultivated legumes of the Mediterranean climax 14
Highly Sensitive Detection of BCR-ABL Kinase Domain Mutations in CML patients by an Ultra-Deep Sequencing Approach 14
Characterization of proteins involved in the mechanism of resistance to Imatinib Mesylate in Chronic Myeloid Leukemia 14
High-avidity cytotoxic lymphocytes specific for a new peotide derived from Preferentially expressed Antigen of Melanoma (PRAME) can target leukemia precursor cells 14
Decreased level of SHP-1 provides an additive survival advantage to Philadelphia Chromosome-positive (Ph+) cells derived from patients with Chronic Myeloid Leukemia (CML) and account for resistance to Imatinib (Ima) treatment 14
Frequenza delle mutazioni c-kit in pazienti affetti da Leucemia mieloide acuta (LAM) caratterizzata da alterazioni del gene del core binding factor (CBF) 14
Diversity of Rhizobium leguminosa rum biovar viciae strains nodulating wild and crop legumes in central-southern Italy 14
Clinical relevance in Chronic Myeloid Leukemia of deletion and insertion events in the tyrosine Kinase domain of BCR-ABL 14
Clinical outcome of Chronic Myeloid Leukemia (CML) patients with deletion and Insertion events (DI) in the Tyrosine Kinase Domain of Bcr-Abl 14
The Expression of shp-1 and SHP-2: A Novel Powerful Predictor of Major Molecular Response (MMR) Achievement in Chronic Myeloid Leukemia Gleevec-Treated Patients Enrolled into the TOPS Clinical Trial 14
Clonal evolution in a case of hepatosplenic T cell lymphoma 13
Use of nodulation pattern, stress tolerance, nodC gene amplification, RAPD-PCR and RFLP-16S rDNA analysis to discriminate genotypes of Rhizobium leguminosarum biovar viciae 13
Increasing BCR-.ABL expression levels and/or occurrence of ABL point mutations not always predict resistance to Imatinib Mesylate in BCR-ABL positive Acute Lymphoblastic Leukemia 13
First case of KIT Ser715del and Jak2 Val617Val mutation in systemic mastocytosis with associated essential thrombocythemia 13
The dynamics of ABL mutations onset in Ph+ Acute Lymphoblastic Leukemia treated with Imatinib Mesylate 13
Immunohistochemical algorithms and gene expression profiling in primary cutaneous B-cell lymphoma 13
Characterization of proteins involved in the mechanism of resistance to Imatinib Mesylate in Chronic Myeloid Leukemia 13
Unravelling the Mechanism of Resistance to Imatinib Mesylate in Chronic Myeloid Leukemia: a Proteomic Approach 13
Clinical relevance in Chronic Myeloid Leukemia of deletion and insertion events in tyrosine kynase domain of BCR-ABL 13
The Expression of shp-1 and SHP-2: A Novel Powerful Predictor of Major Molecular Response (MMR) Achievement in Chronic Myeloid Leukemia Gleevec-Treated Patients Enrolled into the TOPS Clinical Trial 13
The expression of shp-1 andSHP-2: A Novel Powerful Predictor of Major Molecular Response (MMR) Achievement in Chronic Myeloid Leukemia Gleevec-Treated Patients Enrolled into the TOPS Clinical Trial 13
Cytopathology diagnosis of the thyroidal nodule: a review 13
cKIT mutations frequency detected in patients with Acute Myeloid Leukemia (AML) characterized by Core Binding Factor (CBF) rearrangement 13
Reduced levels of SHP1 provides an additive survival advantage to the Ph+ cells of CML patients and may account for resistance to Ima treatment 13
Flow cytometric immunophenotypic and molecular profiles and follow-up in a case of gamma-delta hepatosplenic T-cell Lymphoma 13
Evalution of proteolytic, lipolytic and decarboxylase activity of extremely halophilic bacteria occurring in ripening of salt anchovies 13
The activity of tyrosine Kinase inhibitors on T-cell proliferation and activation 13
Peritumoral Immune Infiltrate as a Prognostic Biomarker in Thin Melanoma 13
Biochimica ematologica in Biochimica del plasma e sistema ematopoietico 12
L'ATTIVITÀ DEGLI INIBITORI DI TIROSINA KINASI (TKI) SULLA PROLIFERAZIONE E L'ATTIVAZIONE DELLE CELLULE T 12
Cytologic, flow cytometry, and molecular assessment of lymphoid infiltrate in fine-needle cytology samples of Hashimoto thyroiditis 12
Frequencies of cKIT mutations detected in patients with Acute Myeloid Leukemia (AML) characterized by Core Binding Factor (CBF) rearrangements 12
First case of S716del mutation in the cKIT gene and V617V mutation in Jak2 gene in a patient affected by essential thrombocytopenia associated to systemic mastocytosis 12
Decrease level of SHP1 provides an additive survival advantage to Philadelphia chromosome-positive (Ph+) cells derived from patients with chronic myeloid leukemia (CML) and account for resistance to Imatinib (Ima) treatment 12
Immunoglobulin heavy and light chains and T-cell receptor beta and gamma chains PCR assessment on cytological samples. A study comparing FTA cards and cryopreserved lymph node fine-needle cytology 12
Reduced levels of SHP1 provides an additive serviva advantage to the PH- cells of CML patients and may account for resistance to IMA treatment 12
Induction of preferentially expressed antigen of melanoma (PRAME)-specific immunity by PRAME-overlapping pentadecapeptides in patients with hematologic malignancies, including chronic myelogenous leukemia 12
La proteina SHP-1 è implicata nella resistenza al trattamenti con Imatinib (Ima) in pazienti affetti da leucemia mieloide cronica (LMC) 11
Primo caso di trombocitemia essenziale (TE) associate a mastocitosi ossea con mutazione S715del del gene c-KIT e V616V del gene JAK2 11
Reduced Expression Level of SHP1 Gives An Additive Survival Advantage to the Ph+ Cells of Chronic Myeloid Leukemia (CML) Patients and Provides a Novel Pretreatment Predictor of Major Molecular Response Achievement in CML Patients 11
Effectiveness of interferon alpha therapy in essential thrombocythemia 11
Light chains expression of lymphoid infiltrate in fine-needle cytology of Hashimoto's Thyroiditis 11
Increasing the BCR-ABL expression levels and/or the occurrence of ABL point mutations does not always predict resistance to Imatinib Mesylate in BCR-ABL positive acute lymphoblastic leukaemia 11
The constitutive activated V617F Janus Kinase 2 (JAK2) induces centrosome abnormalities 11
Clinical relevance in chronic myeloid leukemia of deletion and insertion events in the tyrosine Kinase domain of BCR-ABL 11
Reduced Expression Level of SHP1 Gives An Additive Survival Advantage to the Ph+ Cells of Chronic Myeloid Leukemia (CML) Patients and Provides a Novel Pre-treatment Predictor of Major Molecular Response Achievement in CML Patients 11
The dynamics of ABL mutations onset in PH+ Acute Lymphoblastic Leukemia treated with Imatinib Mesylate 10
UNA BASSA ESPRESSIONE DELLA FOSFATASI SHP-1 CORRELA CON LA RESI-STENZA AL TRATTAMENTO CON INIBITORI DELLE TIROSIN KINASI IN PAZIENTIAFFETTI DA LEUCEMIA MIELOIDE CRONICA 10
Induction of preferentially expressed antigen of melanoma (PRAME)-specific immunity by PRAME-overlapping pentadecapeptides in patients with hematologic malignancies. Including chronic myelogenous leukemia 10
SHP1 expression accounts for resistance to Imatinib treatment in Philadelphia chromosome-positive cells derived from patients with Chronic Myeloid Leukemia 10
La proteina SHP-1 è implicata nella resistenza al trattamenti con Imatinib (Ima) in pazienti affetti da leucemia mieloide cronica (LMC) 9
Totale 837
Salva come PNG Salva come JPEG
Categoria #
all - tutte 6.686
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.686
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/2025329 0 0 0 64 2 4 5 126 14 0 110 4
2025/2026508 62 69 194 90 88 5 0 0 0 0 0 0
Totale 837